Related references
Note: Only part of the references are listed.Cigarette smoking significantly increases basal metabolic rate in patients with rheumatoid arthritis
G. S. Metsios et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
A. Gonzalez et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis
V. F. Panoulas et al.
RHEUMATOLOGY (2008)
Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis
V. F. Panoulas et al.
JOURNAL OF HUMAN HYPERTENSION (2008)
Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review
G. S. Metsios et al.
RHEUMATOLOGY (2008)
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
J. N. Hoes et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Redefining overweight and obesity in rheumatoid arthritis patients
Antonios Stavropoulos-Kalinoglou et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis
V. F. Panoulas et al.
RHEUMATOLOGY (2007)
2007 ESH-ESC practice guidelines for the management of arterial hypertension - ESH-ESC task force on the management of arterial hypertension
Giuseppe Mancia et al.
JOURNAL OF HYPERTENSION (2007)
Association of serum uric acid with cardiovascular disease in rheumatoid arthritis
V. F. Panoulas et al.
RHEUMATOLOGY (2007)
Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis
Kaisa M. Maeki-Petaejae et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis
Enrico Arosio et al.
JOURNAL OF HYPERTENSION (2007)
Unfairness and health:: evidence from the Whitehall II study
Roberto De Vogli et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2007)
Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis - Results of eighteen years of followup from the Early Rheumatoid Arthritis Study
D. L. Mattey et al.
ARTHRITIS AND RHEUMATISM (2007)
Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study
S. A. Karvounaris et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
What effects might anti-TNF alpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNF alpha in cardiovascular pathophysiology
W. G. Dixon et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade
P. Dandona et al.
JOURNAL OF HUMAN HYPERTENSION (2007)
Drug-disease interactions: Losartan effect is not downregulated by rheumatoid arthritis
Noriko Daneshtalab et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events - Meta-analysis of randomized trials
Jingjing Zhang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen
A. Whelton et al.
KIDNEY INTERNATIONAL (2006)
Insulin resistance and impaired beta cell function in rheumatoid arthritis
Patrick H. Dessein et al.
ARTHRITIS AND RHEUMATISM (2006)
Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register
K. Hyrich et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Safety of low dose glucocorticoid treatment in rheumatoid arthritis:: published evidence and prospective trial data
JAP Da Silva et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis
B Caldwell et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2006)
Dietary approaches to prevent and treat hypertension - A scientific statement from the American Heart Association
LJ Appel et al.
HYPERTENSION (2006)
Trends in blood pressure, hypertension control, and stroke mortality: The Minnesota Heart Survey
RV Luepker et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Dyslipidemia and the risk of incident hypertension in men
RO Halperin et al.
HYPERTENSION (2006)
Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study
Vokko P. van Halm et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis
I del Rincón et al.
ARTHRITIS AND RHEUMATISM (2005)
Antiinflammatory action of glucocorticoids - New mechanisms for old drugs
T Rhen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study
M Hakoda et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Analgesic use and risk of subsequent hypertension in apparently healthy men
T Kurth et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Arterial stiffness in chronic inflammatory diseases
MJ Roman et al.
HYPERTENSION (2005)
Relationship between C-reactive protein and arterial stiffness in an asymptomatic population
DA Duprez et al.
JOURNAL OF HUMAN HYPERTENSION (2005)
Impact of nonsteroidal anti inflammatory drugs on the cardioprotective effects of aspirin
SL Corman et al.
ANNALS OF PHARMACOTHERAPY (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects
ML Capone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Persistent sympathetic activation during chronic antihypertensive therapy - A potential mechanism for long term morbidity?
Q Fu et al.
HYPERTENSION (2005)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure
TJ Aw et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Cardiovascular Death in Rheumatoid Arthritis A Population-Based Study
Hilal Maradit-Kremers et al.
ARTHRITIS AND RHEUMATISM (2005)
Lower limb arterial incompressibility and obstruction in rheumatoid arthritis
I del Rincón et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension
LE Bautista et al.
JOURNAL OF HUMAN HYPERTENSION (2005)
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis - A population-based cohort study
H Maradit-Kremers et al.
ARTHRITIS AND RHEUMATISM (2005)
The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus
JR Sowers et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Global burden of hypertension: analysis of worldwide data
PM Kearney et al.
LANCET (2005)
Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study
KJ Warrington et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis
PH Dessein et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Leflunomide in the treatment of rheumatoid arthritis
EK Li et al.
CLINICAL THERAPEUTICS (2004)
Heart failure in rheumatoid arthritis: Rates, predictors, and the effect of anti-tumor necrosis factor therapy
F Wolfe et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Guidelines for management of hypertension: Report of the fourth working party of the British Hypertension Society, 2004 - BHSIV
B Williams et al.
JOURNAL OF HUMAN HYPERTENSION (2004)
Rheumatoid arthritis does not reduce the pharmacodynamic response to valsartan
N Daneshtalab et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
The burden of adult hypertension in the United States 1999 to 2000 - A rising tide
LE Fields et al.
HYPERTENSION (2004)
Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis
N Erb et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2004)
Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study
PC Souverein et al.
HEART (2004)
High intensity exercise or conventional exercise for patients with rheumatoid arthritis? Outcome expectations of patients, rheumatologists, and physiotherapists
M Munneke et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease
L Wei et al.
ANNALS OF INTERNAL MEDICINE (2004)
Cardiovascular risk factors in women with and without rheumatoid arthritis
DH Solomon et al.
ARTHRITIS AND RHEUMATISM (2004)
Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis
HM Kremers et al.
ARTHRITIS AND RHEUMATISM (2004)
Autoantibodies and thrombophilia in RA:: TNFα and TNFα blockers
GF Ferraccioli et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature
GH Dai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
C-reactive protein and the risk of developing hypertension
HD Sesso et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000
I Hajjar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects
I del Rincón et al.
ARTHRITIS AND RHEUMATISM (2003)
Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis
R Klocke et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Rheumatoid arthritis and macrovascular disease
JK Alkaabi et al.
RHEUMATOLOGY (2003)
Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation
M Wong et al.
ARTHRITIS AND RHEUMATISM (2003)
Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis
M Nagata-Sakurai et al.
ARTHRITIS AND RHEUMATISM (2003)
Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome
DPM Symmons
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2002)
Effects of celecoxib and rofecoxib on blood pressure and edema in patients ≥65 years of age with systemic hypertension and osteoarthritis
A Whelton et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Nonnarcotic analgesic use and the risk of hypertension in US women
J Dedier et al.
HYPERTENSION (2002)
Frequency of analgesic use and risk of hypertension in younger women
GC Curhan et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women
EA Bermudez et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
LH Lindholm et al.
JOURNAL OF HYPERTENSION (2002)
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens:: current questions and tentative answers in rheumatology
F Buttgereit et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
PAI-1 in human hypertension: Relation to hypertensive groups
N Srikumar et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials
JM Geleijnse et al.
JOURNAL OF HYPERTENSION (2002)
Leflunomide and hypertension
B Rozman et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Long term efficacy and safety of cyclosporin versus parenteral old in early rheumatoid arthritis:: a three year study of radiographic progression, renal function, and arterial hypertension
TK Kvien et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Low-dose aspirin does not interfere with the blood pressure-lowering effects of anti hypertensive therapy.
A Zanchetti et al.
JOURNAL OF HYPERTENSION (2002)
Effect of indomethacin on the anti hypertensive efficacy of valsartan and lisinopril: a multicentre study
R Fogari et al.
JOURNAL OF HYPERTENSION (2002)
Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: Results from the Iowa women's health study
LA Criswell et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors
WB White et al.
HYPERTENSION (2002)
Residual lifetime risk for developing hypertension in middle-aged women and men - The Framingham Heart Study
RS Vasan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Physician-related barriers to the effective management of uncontrolled hypertension
SA Oliveria et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Can intervention modify adverse lifestyle variables in a rheumatoid population? Results of a pilot study
MM Gordon et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis
PH Dessein et al.
ARTHRITIS RESEARCH (2002)
Influence of cigarette smoking on disease outcome in rheumatoid arthritis
BJ Harrison
CURRENT OPINION IN RHEUMATOLOGY (2002)
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
F Catella-Lawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine
DL Scott et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Blood pressure and inflammation in apparently healthy men
CU Chae et al.
HYPERTENSION (2001)
Risk of cardiovascular events associated with selective COX-2 inhibitors
D Mukherjee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis
A McEntegart et al.
RHEUMATOLOGY (2001)
Is C-reactive protein an independent risk factor for essential hypertension?
LE Bautista et al.
JOURNAL OF HYPERTENSION (2001)
Renin release and the sympathetic nervous system
CL Kaul et al.
DRUGS OF TODAY (2000)
Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial
CHM van den Ende et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
Association of blood pressure with fibrinolytic potential in the Framingham Offspring population
KA Poli et al.
CIRCULATION (2000)
Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction - Findings from National Health and Nutrition Examination Survey III
ES Ford et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Share Paper
